Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Whisky11 is the main for Scotty, & MinimumDamage BASHERS DES

<< Previous

Bullboard Posts

Next >>

Post by PowerofNowon Mar 10, 2021 8:45pm

146 Views

Post# 32769283

Whisky11 is the main for Scotty, & MinimumDamage BASHERS DES

Super obvious check out how Whisky11 interacts with his sly quotes in history. EVERY BASHER on this board would not spend their time here constantly spilling garbage... there won't be any dilution / RS upon Ticker change. No reason for it, & if that was the case the news would have already came out and stock would be halted again. As well, I can guarantee you the last thing the company wants is to halt the stock until commencing with new ticker. Thus, will be a quick 1:1 simple switch over.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record